Banco Bilbao Vizcaya Argentaria S.A. Grows Holdings in McKesson Corporation $MCK

Banco Bilbao Vizcaya Argentaria S.A. increased its holdings in shares of McKesson Corporation (NYSE:MCK) by 57.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,452 shares of the company’s stock after purchasing an additional 1,997 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in McKesson were worth $4,199,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Brighton Jones LLC grew its holdings in shares of McKesson by 46.3% during the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after buying an additional 798 shares during the last quarter. Caxton Associates LLP purchased a new stake in McKesson during the 1st quarter valued at approximately $233,000. Sivia Capital Partners LLC raised its stake in McKesson by 77.9% during the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after acquiring an additional 300 shares during the last quarter. Cetera Investment Advisers lifted its position in McKesson by 0.8% during the 2nd quarter. Cetera Investment Advisers now owns 37,812 shares of the company’s stock worth $27,708,000 after acquiring an additional 297 shares during the period. Finally, Avantax Advisory Services Inc. grew its stake in shares of McKesson by 7.6% in the 2nd quarter. Avantax Advisory Services Inc. now owns 4,556 shares of the company’s stock valued at $3,339,000 after purchasing an additional 320 shares during the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of McKesson in a report on Wednesday, December 10th. Robert W. Baird set a $968.00 price objective on shares of McKesson in a research report on Wednesday, January 14th. Evercore reissued an “outperform” rating on shares of McKesson in a research note on Thursday, March 5th. Weiss Ratings downgraded shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Finally, JPMorgan Chase & Co. raised their target price on shares of McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

Insider Activity

In other news, EVP Leann B. Smith sold 190 shares of the firm’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the transaction, the executive vice president owned 2,989 shares in the company, valued at $2,824,605. This trade represents a 5.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the firm’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last 90 days. Insiders own 0.08% of the company’s stock.

McKesson Trading Up 0.3%

MCK stock opened at $943.43 on Tuesday. The company’s 50-day moving average price is $896.29 and its 200 day moving average price is $828.19. McKesson Corporation has a 52 week low of $637.00 and a 52 week high of $999.00. The company has a market cap of $115.56 billion, a P/E ratio of 27.13, a P/E/G ratio of 1.51 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. The company had revenue of $106.16 billion during the quarter, compared to analysts’ expectations of $105.98 billion. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm’s quarterly revenue was up 11.4% compared to the same quarter last year. During the same period last year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities research analysts expect that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio (DPR) is presently 9.43%.

McKesson Company Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.